CAT

716.9

+2.3%↑

GE

291.06

-0.69%↓

RTX

194.44

-1.08%↓

GEV.US

911.22

+3.25%↑

BA

196.73

-1.17%↓

CAT

716.9

+2.3%↑

GE

291.06

-0.69%↓

RTX

194.44

-1.08%↓

GEV.US

911.22

+3.25%↑

BA

196.73

-1.17%↓

CAT

716.9

+2.3%↑

GE

291.06

-0.69%↓

RTX

194.44

-1.08%↓

GEV.US

911.22

+3.25%↑

BA

196.73

-1.17%↓

CAT

716.9

+2.3%↑

GE

291.06

-0.69%↓

RTX

194.44

-1.08%↓

GEV.US

911.22

+3.25%↑

BA

196.73

-1.17%↓

CAT

716.9

+2.3%↑

GE

291.06

-0.69%↓

RTX

194.44

-1.08%↓

GEV.US

911.22

+3.25%↑

BA

196.73

-1.17%↓

Search

Korn-Ferry International

Ouvert

SecteurIndustrie

62.71 -0.56

Résumé

Variation du prix de l'action

24h

Actuel

Min

61.24

Max

63.11

Chiffres clés

By Trading Economics

Revenu

-8.1M

66M

Ventes

-4.8M

725M

P/E

Moyenne du Secteur

12

61.065

Rendement du dividende

3.16

Marge bénéficiaire

9.122

Employés

9,253

EBITDA

-20M

114M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+13.34% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.16%

2.23%

Prochains Résultats

17 juin 2026

Date du Prochain Dividende

15 avr. 2026

Date du Prochain Détachement de Dividende

27 mars 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-90M

3.2B

Ouverture précédente

63.27

Clôture précédente

62.71

Sentiment de l'Actualité

By Acuity

50%

50%

177 / 406 Classement par Industrials

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Korn-Ferry International Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 mars 2026, 23:47 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mars 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mars 2026, 21:51 UTC

Acquisitions, Fusions, Rachats

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mars 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mars 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mars 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mars 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mars 2026, 22:42 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

23 mars 2026, 22:42 UTC

Market Talk
Principaux Événements d'Actualité

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mars 2026, 22:40 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mars 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mars 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mars 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mars 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mars 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mars 2026, 22:20 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mars 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mars 2026, 22:19 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mars 2026, 22:18 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mars 2026, 22:15 UTC

Acquisitions, Fusions, Rachats

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mars 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mars 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mars 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mars 2026, 21:32 UTC

Résultats

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mars 2026, 21:10 UTC

Principaux Événements d'Actualité

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mars 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mars 2026, 20:50 UTC

Market Talk
Résultats
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

Korn-Ferry International prévision

Objectif de Prix

By TipRanks

13.34% hausse

Prévisions sur 12 Mois

Moyen 70 USD  13.34%

Haut 75 USD

Bas 65 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

56 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

177 / 406Classement par Industrie

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Korn-Ferry International

Korn Ferry, together with its subsidiaries, engages in the provision of organizational consulting services worldwide. The company offers consulting services for organizational structure, culture, performance, development, and people; and builds, sells, and delivers Digital talent technology products, including a talent suite that enables clients to make critical talent decisions in the flow of work across talent acquisition and talent development. It also provides executive search services that helps organizations to recruit board level, chief executive, and other C-suite/senior executive, as well as general management talent; enterprise talent acquisition solutions for permanent and interim placements at the professional level middle and upper management, as well as senior executives; and recruitment outsourcing and projects solutions for clients' recruitment requirements. The company operates cloud human resources platforms comprising Korn Ferry Architect, for providing organization and talent planning architecture for an agile and future-focused workforce; Korn Ferry Assess, for empowering leaders to take actions that lead to business success; Korn Ferry Listen, for deploying engagement surveys and benchmark employee engagement; Korn Ferry Sell, for developing and replicating sales strategies; and Korn Ferry Pay, a self-service pay solution, that provides global data and insights needed in real-time to make decisions on employee compensation programs. It serves public and private companies, middle-market and emerging growth companies, and government and non-profit organizations, as well as consumer markets, financial services, healthcare, life sciences, industrial, technology, and specialties sectors. The company was formerly known as Korn/Ferry International and changed its name to Korn Ferry in January 2019. Korn Ferry was founded in 1969 and is based in Los Angeles, California.
help-icon Live chat